Neotame vs Brominated Flame Retardants: which is worse?

What is Neotame?

Neotame is a synthetic dipeptide sweetener — a derivative of aspartame with a 3,3-dimethylbutyl group added to block aspartame's metabolism, preventing the release of phenylalanine. This means it is safe for people with phenylketonuria (PKU), unlike aspartame. It is approximately 7,000-13,000 times sweeter than sucrose.

What is Brominated Flame Retardants?

Brominated flame retardants (BFRs) are a class of synthetic chemicals added to consumer products and materials to reduce flammability. They include polybrominated diphenyl ethers (PBDEs), hexabromocyclododecane (HBCD), and others. While not direct food additives, they contaminate the food supply through environmental pathways and food packaging.

Documented risks

Neotame: Neotame is one of the newer synthetic sweeteners with a shorter safety track record. A 2023 study published in Frontiers in Nutrition found that neotame damaged intestinal epithelial cells in vitro and disrupted the gut microbiome in mice — including reducing beneficial bacteria and increasing bacterial invasion of intestinal cells. The study observed effects at concentrations that could be achievable through high consumption of neotame-containing products. The FDA has set an ADI of 0.3 mg/kg/day, one of the lower sweetener ADIs, reflecting a conservative safety margin. Limited long-term human safety data exist compared to aspartame, acesulfame K, or saccharin, which have been used for decades. EFSA's 2010 opinion found no safety concern at permitted levels. The Frontiers in Nutrition 2023 gut study represents new concerning findings that warrant further investigation.

Brominated Flame Retardants: PBDEs and other BFRs are endocrine disruptors, neurodevelopmental toxicants, and probable carcinogens. They accumulate in human adipose tissue, breast milk, and blood. PBDEs were found in 100% of samples in multiple US population biomonitoring studies. US women have PBDE body burdens 10-100 times higher than European women, reflecting the US's historically heavy PBDE use before bans. Neurodevelopmental effects: multiple studies have associated prenatal PBDE exposure with lower IQ, attention deficits, and behavioral problems in children. A 2012 Environmental Health Perspectives study found inverse associations between PBDE cord blood levels and child IQ and behavioral outcomes. Thyroid disruption: BFRs structurally mimic thyroid hormones and compete with thyroid hormone binding proteins, disrupting the thyroid axis — critical for fetal brain development. Carcinogenicity: some PBDEs are associated with thyroid cancer risk in human studies. PBDEs enter the food supply primarily through fatty fish (salmon, tuna), meat, dairy, and some contaminated produce from biosolid-amended soils.